e-learning
resources
Munich 2014
Wednesday, 10.09.2014
Genetics and environmental factors underlying asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: GENE ENVIRONMENT INTERACTION ANALYSIS OF OBESITY AND ASTHMA
A. Couto Alves, M. R. Jarvelin, A. Walley (London, United Kingdom)
Source:
International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Session:
Genetics and environmental factors underlying asthma and COPD
Session type:
Poster Discussion
Number:
4774
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Couto Alves, M. R. Jarvelin, A. Walley (London, United Kingdom). LATE-BREAKING ABSTRACT: GENE ENVIRONMENT INTERACTION ANALYSIS OF OBESITY AND ASTHMA. Eur Respir J 2014; 44: Suppl. 58, 4774
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
LATE-BREAKING ABSTRACT: THE FATE OF INHALED DRUG: CORTICOSTEROID PARTICLE SIZE EFFECTS IN ASTHMA
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013
LATE-BREAKING ABSTRACT: PERSISTENTLY HIGH EXHALED NITRIC OXIDE AND LUNG FUNCTION DECLINE IN PATIENTS WITH CONTROLLED ASTHMA AT BASELINE
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
LATE-BREAKING ABSTRACT: ASSOCIATION OF SEVERE EXACERBATION WITH FEV1 DECLINE AND LOSS OF AIRWAY REVERSIBILITY IN ASTHMA
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Late Breaking Abstract - RHEOLOGY AS A TOOL TO ASSESS COPD DIAGNOSIS COMPARED TO ASTHMA DIAGNOSIS, AND TO EVALUATE THE EFFICIENCY OF TREATMENTS
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
LATE-BREAKING ABSTRACT: PRECLINICAL TESTING OF THERAPEUTIC WNT/beta-CATENIN ACTIVATION IN HUMAN 3D LUNG TISSUE CULTURES
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Late Breaking Abstract - ORAL FORMULATION OF ANGIOTENSIN-(1-7) PROMOTES RESOLUTION OF EOSINOPHILIC AND NEUTROPHILIC INFLAMMATION IN AN EXPERIMENTAL ASTHMA MODEL
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
CARDIOVASCULAR RISK (CVR) AND EFFECTS ON THE QUALITY OF LIFE AFTER A PHYSICAL REHABILITATION PROGRAM ON COPD PATIENTS BASED ON THEIR PHENOTYPE: EXACERBATOR (E) OR NON-EXACERBATOR (NE)
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
LATE-BREAKING ABSTRACT: GENDER DIFFERENCES IN ASTHMATIC CHILDREN
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
EVALUATION OF SMALL AIRWAY DISEASE (SAD) IN ASTHMA. CONCORDANCES AND DISCREPANCES BETWEEN DIFFERENT TECHNIQUES.
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
ARE THERE CLINICALLY RELEVANT BENEFITS IN A STRUCTURED PROGRAM OF PHYSICAL ACTIVITY IN COPD? ACTIVEPOC STUDY.
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020
SLEEP APNOEA AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASE: CURRENT EVIDENCE, BASIC MECHANISMS AND RESEARCH PRIORITIES.
Source: Eur Respir J 2007; 29: 614
Year: 2007
INCREASED MYOSTATIN AS A NEGATIVE REGULATOR OF MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: CLINICAL IMPLICATIONS
Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation
Year: 2020
Late Breaking Abstract - PULMONARY REHABILITATION IN POST - COVID SUBJECTS WITH MODERATE LUNG RESTRICTION, A CASE SERIES.
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021
THE IMPACT OF PULMONARY REHABILITATION ON PHYSICAL ACTIVITY AND PHYSICAL FITNESS LEVELS IN LUNG TRANSPLANT CANDIDATES; PRELIMINARY STUDY RESULTS
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017
PAIN AND FRAILTY IN COPD PATIENTS: RELATIONSHIP AND IMPACT ON WELLBEING AND HEALTH STATUS
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
BENEFITS OF EARLY DIAGNOSIS AND TREATMENT OF OBSTRUCTIVE SLEEP APNEA-HYPOPNEA SYNDROME IN PATIENTS WITH ACUTE ISCHEMIC STROKE: SASS (Sleep Apnea in Stroke patients Study)
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019
ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP)
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018
WHAT TOOLS AND RESOURCES DO PULMONARY REHABILITATION TEAMS USE TO DELIVER EDUCATION?
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
LUNG ADENOCARCINOMA: CLINICAL CHARACTERISTICS, MOLECULAR STUDY, DIAGNOSIS AND TREATMENT.
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept